Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0000950170-24-130588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-11-25 | 2024-11-21 | GMED | Scavilla Daniel T | Pres, CEO, Dir | M - OptEx | $43.65 | +130.0K | 130.0K | New | +$5.67M |
| DT | 2024-11-25 | 2024-11-21 | GMED | Scavilla Daniel T | Pres, CEO, Dir | S - Sale+OE | $85.00 | -130.0K | 0 | -100% | -$11.05M |
| DMT | 2024-11-25 | 2024-11-21 | GMED | Scavilla Daniel T | Pres, CEO, Dir | M - OptEx | $0.00 | -130.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-21 | M | A | 50,000 | $43.77 | 50,000 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-11-21 | M | A | 80,000 | $43.58 | 130,000 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-11-21 | S | D | 130,000 | $85.00 | 0 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-11-21 | M | D | 50,000 | $0.00 | 0 | D | $43.77 · — to 2028-01-22 | 50,000 Class A Common Stock | (F2) These options were granted on January 22, 2018 and are fully vested. |
| 5 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-11-21 | M | D | 80,000 | $0.00 | 0 | D | $43.58 · — to 2029-01-22 | 80,000 Class A Common Stock | (F3) These options were granted on January 22, 2019 and are fully vested. |